Schedule 13G ownership disclosure
CONMED Corp
Common Stock · CUSIP: 207410101
Event date: 2025-09-30
- Filing-level shares
- 1,032,733.00
- Percent of class
- 3.3%
- Capital Research Global Investors
Shares: 1,032,733.00 · Class: 3.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-25-000242
- Form type
- SCHEDULE 13G/A
- Filer
- CONMED Corp
- CIK
- CIK 816956
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership